The Social Course of Drug Injection and Sexual Activity among YMSM and Other High-Risk Youth: An Agenda for Future Research

Journal of Urban Health

Volumn 80, Issue 3, 2003, Pages

  Clatts, Michael C ^a   Goldsamt, Lloyd ^a   Neaigus, Alan ^a   Welle, Dorinda L ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

High risk youth; HIV infection; IDUs; Sexual risks and injection initiation; Social and sexual networks; Social course of drug injection; YMSM

Indexed keywords

ADOLESCENT; ADULT; CONFERENCE PAPER; EXPOSURE; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOCIAL ASPECT; VIRUS INFECTION;

EID: 0742301332     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (80)

1. Garfein RS, Vlahov D, Galai N, et al. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotrophic viruses. Am J Public Health. 1996;86:655-661.
2. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 2001;13(2).
3. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;86:642-654.
4. Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology. 2000;31(3):777-782.
5. Williams I. Epidemiology of hepatitis C in the United States. Am J Med. 1999;107(6B): 2S-9S.
6. National Institutes of Health. Management of Hepatitis C. September 12, 2002;19(1).
7. Clatts MC, Sotheran JL, Heimer R, Goldsamt L. Interdisciplinary research on transmission of blood-borne pathogens among drug injectors: applications of ethnography in epidemiology and public health. In: Marshall PA, Singer M, Clatts MC, Needle R, Lambert E, eds. Integrating Cultural, Observational, and Epidemiology Approaches in the Prevention of Drug Abuse and HIV/AIDS: Current Status and Future Prospects. Rockville, MD: National Institute on Drug Abuse; 1999:74-91.
8. Thorpe LE, Ouellet LJ, Hershow R, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002;155(7):645-653.
9. National Institute on Drug Abuse. Epidemiologic Trends in Drug Abuse, Community Epidemiology Working Group: Volume II. Rockville, MD: National Institute on Drug Abuse; June 2003. NIH Pub. No. 03-5110A.
10. National Institute on Drug Abuse. Epidemiologic Trends in Drug Abuse, Community Epidemiology Working Group: Executive Summary, Volume I. Rockville, MD: National Institute on Drug Abuse; December 1999. NIH Pub. No. 00-4739.
11. Chitwood D, Comefored M, Weatherby NL. The initiation of the use of heroin in the age of crack. In: Inciardi JA, Harrison LSD, eds. Heroin in the Age of Crack Cocaine. Thousand Oaks, CA: Sage Publications; 1998:1-76.
12. Roy E, Haley N, Leclerc P, Cedras L, Boivin JF. Drug injection among street youth: the first time. Addiction. 2002;97(8):1003-1009.
13. Zinkernagel C, Naef MR, Bucher HC, Ladewig D, Gyr N, Battegay M. Onset and pattern of substance use in intravenous drug users of an opiate maintenance program. Drug Alcohol Depend. 2001;64(1):105-109.
14. National Institute on Drug Abuse. Epidemiologic Trends in Drug Abuse, Community Epidemiology Working Group: Volume II. Rockville, MD: National Institute on Drug Abuse; June 2002. NIH Pub. No. 03-5109A.
15. Des Jarlais DC, Casriel C, Friedman SR, et al. AIDS and the transition to illicit drug injection - results of a randomized trial prevention program. Br J Addict. 1992;87:493-498.
16. Agar M, Reisinger HS. Numbers and patterns: heroin indicators and what they represent. Hum Organ. 1999;58(4):365-374.
17. Hamid A, Curtis R, McCoy K, et al. The heroin epidemic in New York City: current status and prognosis. J Psychoactive Drugs. 1999;41:375-391.
18. Johnston LD, O'Malley PM, Bachman JG. National Survey Results on Drug Use From the Monitoring the Future Study. Volume 1: Secondary School Students. Rockville MD: National Institute on Drug Abuse; 1999. NIH Publication No. 99-4660.
19. Johnson WA, Ouellet LJ. The injection of crack cocaine among Chicago drug users. Am J Public Health. 1996;86(2):266.
20. Clatts MC, Davis R. A demographic and behavioral profile of homeless youth in New York City: implications for AIDS educations and prevention. Med Anthropol Q. 1999;13(3):265-374.
21. Clatts MC, Welle DL, Goldsamt LG. Reconceptualizing the interaction of drug and sexual risk among MSM speed users: notes toward an ethno-epidemiology. AIDS Behav. 2001;5(2):115-130.
22. National Institute on Drug Abuse. Epidemiologic Trends in Drug Abuse, Community Epidemiology Working Group: Highlights and Executive Summary, Volume I. Rockville, MD: National Institute on Drug Abuse; December 2001. NIH Pub. No. 02-5109.
23. Gorman EM, Carroll RT. Substance abuse and HIV: considerations with regard to methamphetamines and other recreational drugs for nursing practice and research. J Assoc Nurs AIDS Care. 2000;112:51-62.
24. Substance Abuse and Mental Health Services Administration (SAMHSA). Drug Abuse Warning Network: Preliminary Data. Washington DC: Author; 1998.
25. Lankenau S, Clatts MC. Ketamine injection among high-risk youth: preliminary findings from NYC. J Drug Issues. 2002;323(3):893-906.
26. Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000;14:717-726.
27. Diaz T, Des Jarlais DC, Vlahov D, et al. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health. 2001;91:23-30.
28. Osmond DH, Page K, Wiley J, et al. HIV infection in homosexual and bisexual men 18 to 29 years of age: the San Francisco Young Men's Health Study. Am J Public Health. 1994;84(12):1933-1937.
29. Dean L, Meyer I. HIV prevalence and sexual behavior in a cohort of New York City gay men (aged 18-24). J Acquir Immune Defic Syndr. 1995;8:208-211.
30. Koblin BA, Torian LV, Guilin V, Ren L, MacKellar DA, Valleroy LA. High prevalence of HIV infection among young men who have sex with men in New York City. AIDS. 2000;14(12):1793-1800.
31. Valleroy LA, MacKellar DA, Karon JM, et al. HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group. JAMA. 2000; 284(2):198-204.
32. Ekstrand ML, Stall RD, Paul JP, Osmond DH, et al. Gay men report high rates of unprotected anal sex with partners of unknown or discordant HIV status. AIDS. 1999; 13:1525-1533.
33. Stall R, Paul JP, Greenwood G, et al. Alcohol use, drug use and alcohol-related problems among men who have sex with men: the Urban Men's Health Study. Addiction. 2001; 96:1589-1601.
34. Catania JA, Osmond D, Stall RD, et al. The continuing HIV epidemic among men who have sex with men. Am J Public Health. 2001;91:907-914.
35. Deren SA, Estrada A, Stark M, et al. A multi-site study of sexual orientation and injection drug use as predictors of HIV serostatus in out-of-treatment male drug users. J Acquir Immune Defic Syndr. 1997;15:289-295.
36. Elder GH Jr. Families and lives: some developments in life course studies. In: Hareven T, Plakans A, eds. Family History at the Crossroads. Princeton, NJ: Princeton University Press; 1987:255-268.
37. Ekstrand ML, Coates TJ. Maintenance of safer sexual behaviors and predictors of risky sex: the San Francisco Men's Health Study. Am J Public Health. 1990;80:973-977.
38. Hospers HJ, Kok G. Determinants of safe and risk-taking sexual behavior among gay men: a review. AIDS Educ Prev. 1995;7(1):74-96.
39. Morris M, Pramualratana A, Podhisita C, et al. The relational determinants of condom use with sex partners in Thailand. AIDS. 1995;9:507-515.
40. Chen SY, Weide D, McFarland W. Are the recent increases in sexual risk behavior among older or younger men who have sex with men? Answer: Both. AIDS. 2003; 17(6):942-943.
41. Katz MH, Schwarcz SK, Kellogg TA, et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health. 2002;92(3):388-394.
42. Misovich SJ, Fisher JD, Fisher WA. Close relationship and elevated HIV risk behavior: evidence and possible underlying psychological processes. Rev Gen Psychol. 1997;1(1):72-107.
43. Chen SY, Gibson S, Katz MH, et al. Continuing increases in sexual risk behavior and sexually transmitted diseases among men who have sex with men: San Francisco, Calif, 1999-2001, USA. Am J Public Health. 2002;92(9):1387-1388.
44. Stall R, Barrett D, Bye L, et al. A comparison of younger and older gay men's HIV risk-taking behaviors: the Communication Technologies 1989 cross-sectional survey. J Acquir Immune Defic Syndr. 1992;5(7):682-687.
45. Buchbinder S, Judson D, McKirman D, et al. Predictors of seroconversion in high risk gay men. Proceedings of the 10th International Conference on AIDS. 1994; Yokohama, Japan.
46. MacQueen KM. The epidemiology of HIV transmission: trends, structure, and dynamics. Annu Rev Anthropol. 1994;23:509-526.
47. Laumann EO, Gagnon JH, Michael RT, Michaels S. The Social Organization of Sexuality: Sexual Practices in the United States. Chicago, IL; University of Chicago Press; 1995.
48. Morris M, Zavisca J, Dean L. Social and sexual networks: their role in the spread of HIV/AIDS among young gay men. AIDS Educ Prev. 1995;7(suppl):24-35.
49. Larzelere RE, Klein DM. Methodology. In: Sussman MB, Steinmetz SK, eds. Handbook of Marriage and the Family. New York, NY: Plenum Press; 1987:125-155.
50. Stueve A, O'Donnell L, Duran R, San Doval A, Geier J. Being high and taking sexual risks: findings from a multi-site survey of urban young men who have sex with men. AIDS Educ Prev. 2002;14(6):482-495.
51. Waldo CR, McFarland W, Katz MH, MacKellar D, Valleroy LA. Very young gay and bisexual men are at risk for HIV infection: the San Francisco Bay Area Young Men's Survey II. J Acquir Immune Defic Syndr. 2000;24(2):168-174.
52. Coxon AP, Coxon NH, Weatherburn P, et al. Sex role separation in sexual diaries of homosexual men. AIDS. 1993;(6):877-882.
53. Ostrow D, McKirnan D. Prevention of substance-related high-risk sexual behavior among gay men: critical review of the literature and proposed harm reduction approach. J Gay Lesbian Med Assoc. 1997;1(2):97-100.
54. Kipke MD, Unger J, O'Connor S, et al. Street youth, their peer group affiliation and differences according to residential status, subsistence patterns, and use of services. Adolescence. 1997;32(127):655-669.
55. Clatts MC, Hillman DJ, Atillasoy A, Davis WR. Lives in the balance: an ethnographic profile of homeless youth in New York City. In: Bluestein J, Levine C, eds. Medical Decision-Making for Adolescents Who Are Alone. New Brunswick, NJ: Cambridge University Press; 1999;335-390.
56. Neaigus A, Friedman SR, Curtis R, et al. The relevance of drug injectors' social networks and risk networks for understanding and preventing HIV infection. Soc Sci Med. 1994;38(1):67-78.
57. Neaigus A, Friedman SR, Kottiri BJ, Des Jarlais DC. HIV risk networks and HIV transmission among injecting drug users. Eval Prog Plann. 2001;24:221-226.
58. Klovdahl AS. Social networks and the spread of infectious diseases: the AIDS example. Soc Sci Med. 1985;21:1203-1216.
59. Fennema JSA, van Ameijden EJC, van dan Hoek JAR, Coutinho RA. The relative importance of young and recent-onset injection drug users on HIV-1 epidemic in Amsterdam. Addiction. 1997;92(11):1457-1465.
60. Friedman SR, Des Jarlais DC, Neaigus A, et al. AIDS and the new injector. Nature. 1989;339:333-334.
61. Neaigus A, Friedman SR, Jose B, et al. High risk personal networks and syringe sharing as risk factors for HIV infection among new injectors. J Acquir Immune Defic Syndr. 1996;11:499-509.
62. Nicolosi A, Leite ML, Musicco M, Molinari S, Lazzarin A. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. Am J Epidemiol. 1992;135:225-233.
63. Vlahov D, Munoz A, Anthony JC, et al. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol. 1990;132:847-856.
64. Kleinman PH, Goldsmith DS, Friedman SR, et al. Knowledge about and behaviors affecting the spread of AIDS: a street survey of intravenous drug users and their associates in New York City. Int J Addict. 1990;25:345-361.
65. Lima ES, Friedman SR, Bastos FI, et al. Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro. Addiction. 1994;89: 689-698.
66. van den Hoek JAR, Coutinho RA, van Haastrecht HJA, et al. Prevalence and risk factors for HIV infection among drug users and drug using prostitutes in Amsterdam. AIDS. 1988;2:55-60.
67. Friedman SR, Neaigus A, Jose B, et al. Sociometric networks and risk for HIV infection. Am J Public Health. 1987(8):1289-1296.
68. Friedman SR, Kottiri BJ, Neaigus A, et al. Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. Am J Epidemiol. 2000;152(10):913-922.
69. Klovdahl AS, Potterat JJ, Woodhouse DE, et al. Social networks and infectious disease: the Colorado Springs Study. Soc Sci Med. 1994;38:79-88.
70. Rothenberg RB, Woodhouse DE, Potterat JJ, et al. Social networks in disease transmission: the Colorado Springs Study. In: Needle RH, Genser SG, Trotter RT, eds. Social Networks, Drug Abuse, and HIV Transmission. Rockville, MD: National Institute on Drug Abuse; 1995:3-19.
71. Woodhouse DE, Rothenberg RB, Potterat JJ, et al. Mapping a social network of heterosexuals at high risk for HIV infection. AIDS. 1994;8:1331-1336.
72. Neaigus A, Friedman SR, Goldstein MF, Ildefonso G, Curtis R, Jose B. Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. In: Needle RH, Genser SG, Trotter, RT, eds. Social Networks, Drug Abuse and HIV Transmission. Rockville, MD: National Institute on Drug Abuse; 1995:20-37. NIDA Research Monograph 151.
73. Hoffmann JP, Su SS, Pach A. Changes in network characteristics and HIV risk behavior among injection drug users. Drug Alcohol Depend. 1997;46(1-2):41-51.
74. Barnard M. Risky business: the relationship between prostitution, injection drug use and HIV related risk behavior among a sample of Glasgow street working prostitutes. Int J Drug Policy. 1993;4(3):1-6.
75. Latkin CA, Mandell W, Vlahov D, et al. Personal network characteristics as antecedents to needle-sharing and shooting gallery attendance. Soc Networks. 1995;17(3-4):219-228.
76. Friedman SR, Jose B, Neaigus A, et al. Consistent condom use in relationships between seropositive injecting drug users and sex partners who do not inject drugs. AIDS. 1994; 8:357-361.
77. Trotter RT II, Baldwin JA, Bowen AM. Network structure and proxy network measures of HIV, drug and incarceration risks for active drug users. Connections. 1995;18(1):89-104.
78. Diez-Roux AV. Investigating neighborhood and area effects on health. Am J Public Health. 2001;91:1783-1789.
79. Blankenship KM, Bray SJ, Merson MH. Structural interventions in public health. AIDS. 2000;14(suppl 1):S11-S21.
80. Rhodes T, Hunter GM, Stimson GV, et al. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity, and risk behavior. Addiction. 1996;91(10):11457-1467.